Ask yourselves how the early investors felt who had endured the...

Ask yourselves how the early investors felt who had endured the IPO 2017 ,20c, and the decline to these exact same price levels, prior to the phase 1 trial starting.

Then ask yourselves how they felt when the trial started.
Take a look for yourselves.

How does a market value it at 200m mc ? looking at a new worldwide paradigm in diagnostics.
Nothing has changed, rather it has de-risked from Phase 1 bio kinetics / safety + MRI contrast.
Same train, heading into phase 2 trials. What will the market do, when again it is alerted to the prize that potentially awaits on the success case ? Everything in the market, has to factor what is that prize, risk off, in order to wager a fraction of that, risk on.